Kantar Health, a global healthcare consulting and research firm, turned to Concord to help enhance one of its flagship products, Epi Database. Epi Database is an online epidemiology database used by a majority of the top 20 global pharmaceutical companies to find market potential for new drugs, conduct drug discovery prioritization and make go/no go decisions. Demand for the Epi Database grew as Kantar Health’s pharma clients developed new use cases for the data, eventually necessitating increased analysis functionality within the interface. The previous database interface had limited comparison abilities and was only available in a tabular format for clients to interact with.
Leveraging Concord's proven INSIGHT framework for developing dashboards, Concord worked with the Epidemiology team to understand their client’s latest use cases, which allowed the team to pinpoint gaps in the existing tool, identify key business questions, and define common analysis paths. These findings helped us create a fully interactive dashboard, complete with stunning visuals and row level security, to augment the existing tabular database and provide Kantar Health’s clients with insights that were not possible with the previous tool.
Kantar Health now has another tool to help its clients make informed, data-driven decisions and was so pleased with the end product that they have tasked Concord with creating a similar dashboard for their CancerMPact database.
"We wanted to add more visuals given our current format was tables with lots of numbers. Using Tableau we can now make comparisons across diseases and countries quicker and easier."
- Carey Strader, Product Owner at Kantar
Not sure on your next step? We'd love to hear about your business challenges. No pitch. No strings attached.
